With over 200 known types—and roughly 75 percent of those considered not harmful—the National Institute of Health (NIH) reports that human papillomavirus (HPV) is the most common sexually transmitted disease in the United States. In fact, most sexually active women and men become infected with HPV, and the majority of those infections are cleared by the body’s immune system, leading to recovery from the disease without symptoms or complications and with HPV-specific antibodies in place to help prevent future infections. Indeed, more than 90 percent of those infected naturally clear the infection from the body within two years. Still, in 2023, with an estimated population of 334 million people in the U.S., the American Cancer Society estimated that over 30,000 of those (.009 percent) would become infected with HPV-related cancers, with 8,000 deaths (.002 percent) for the HPV types targeted by Merck’s Gardasil 9 vaccine. Currently entrenched in a lawsuit that alleges it causes ovarian failure and infertility, Gardasil is the only HPV vaccine available in this country.

What exactly is HPV? Human papillomaviruses are double-stranded DNA viruses found in the squamous epithelial cells on the surface of the skin and mucous membranes of the body. Most HPV types (75 percent) are spread by skin-to-skin contact and are not sexually transmitted. Cutaneous HPV types can be found on the arms, hands, feet, and legs and are associated with common warts. Again, with more than 200 related viruses, sexually transmitted HPVs are spread through vaginal, anal, and oral sex and are categorized into two groups: low-risk and high-risk. According to the National Cancer Institute (NCI) at the NIH, high-risk HPVs—of which there are twelve—are not always controlled by the immune system. To prevent HPV infection, and thus, it claims up to 90 percent of HPV-caused cancers and genital warts, the NCI advises:

“The HPV vaccine Gardasil 9 protects against infection from nine HPV types, including the seven types that cause most HPV-related cancers (types 16, 18, 31, 33, 45, 52, and 58) and the two low-risk types that cause most genital warts (types 6 and 11). HPV vaccination offers the most protection when given to girls and boys at ages 9–12.

It is important for everyone to get vaccinated, because anyone, regardless of their sex, can develop HPV-related cancers. Vaccination can also reduce the spread of HPV that causes cancer to other people.”

The National Cancer Institute (which, not surprisingly, receives funding from the pharmaceutical industry) reports that when a high-risk HPV infection persists for many years, it can lead to cell changes. If untreated, these changes may worsen over time and become precancerous and then cancerous, leading to cervical cancer, anal cancer, oropharyngeal cancer, penile cancer, vulvar cancer, and vaginal cancer. These cancers are in the thin, flat cells (squamous cells) that line the inner surface of the parts of the body where HPV infects cells. With over 47,100 new cases of cancer each year in parts of the body where HPV is found, as noted by NCI, most HPV-related cancers are called squamous cell carcinomas. Some cervical cancers come from HPV infection of glandular cells in the cervix and are called adenocarcinomas. Of the 47,100 new cases each year, NCI reports that about 37,300 of those are caused by HPV. It is unclear whether these individuals received the Gardasil vaccine.

So, what is driving the persistent controversy surrounding Merck & Co.’s Gardasil vaccine, which generated a whopping $8.6 billion in revenue in 2024? Besides being labeled by some as the single worst mass vaccine that we’ve ever seen,” (that suggestion isn’t that far-fetched considering the COVID-19 jab disaster), Gardasil’s Merck will soon face a jury trial defending against claims that the company falsely promoted the Gardasil vaccine as safe and effective. With claims of ovarian failure that led to infertility in women who have taken Gardasil in the last few years, the Complaint asserts that Merck was aware of Gardasil’s serious side effects, including death, and made a deliberate decision not to warn medical providers and the public—its consumers—of the shot’s harmful risks. These claims are long-standing and not isolated to the most recent lawsuit. Indeed, since 2006, Gardasil has been pitched as the best way to prevent cancers, including cervical cancer.

But does Gardasil really prevent cervical cancer? Good ole Merck insists it halts cancer-causing infections before they cause harm, but, as noted by Dr. Sin Hang Lee, there’s no hard evidence that Gardasil prevents cervical cancer itself. A recent Substack by Dr. Mercola pointed out, “[Gardasil] has been shown to cut down on pre-cancer spots – little warning signs that actually go away on their own,” adding, “but no big, long-term studies prove it lowers actual cancer rates.” Moreover, before Gardasil, simple pap smears caught potential problems early, “slashing cervical cancer rates big time,” dropping cases from 44 to 8.8 per 100,000 women.

Clearly, autoimmune disorder-causing Gardasil is not all that it’s cracked up to be. That revelation comes as no shock, given that the profit-driven companies behind scams like Gardasil rely on keeping Americans unwell. And the worst part is that their scheme includes young boys and girls 9 – 12 years old who are already victims of ultra-processed foods, a nearly 100-dose vaccination schedule, medications for attention, grooming in schools, the experimental gene-damaging COVID-19 jab, and the list goes on. Thank God for Robert F. Kennedy Jr., who has voiced concern over Gardasil. In 2024, when speaking about Gardasil, Kennedy remarked:

“Gardasil is probably the single worst mass vaccine that we’ve ever seen. This vaccine targets millions of preteens and teens for whom the risk of dying from cervical cancer is zero. The death rates in the Gardasil trials were 37 times the death rates for cervical cancer.

Children who take the Gardasil vaccine are 37 times more likely to die from the vaccine than they are to die from cervical cancer. So the problem with Gardasil, like most vaccines, is it was never tested against a true placebo, an inert placebo.

And CDC and HHS say if you don’t test it against a true placebo, it’s not science. The entity that is actually performing the study and paying for this study is Merck. So Merck got to decide which injuries were being caused by Gardasil and which were just bad coincidences.

And because it had that power, it just wrote them all off as bad coincidences. You can do that when there’s no placebo because the injuries they were seeing in the control group, which was the girls were getting aluminum neurotoxins, were identical to the injuries they were getting in the Gardasil group.

So they said, well, we don’t have to report any of these as vaccine injuries. They were able to license something that is insanely dangerous.”

 

 

Generic avatar

Tracy Beanz & Michelle Edwards

Tracy Beanz is an investigative journalist, Editor-in-Chief of UncoverDC, and host of the daily With Beanz podcast. She gained recognition for her in-depth coverage of the COVID-19 crisis, breaking major stories on the virus’s origin, timeline, and the bureaucratic corruption surrounding early treatment and the mRNA vaccine rollout. Tracy is also widely known for reporting on Murthy v. Missouri (Formerly Missouri v. Biden,) a landmark free speech case challenging government-imposed censorship of doctors and others who presented alternative viewpoints during the pandemic.